Nalaganje...

Ubiquitin Receptor RPN13 Mediates the Inhibitory Interaction of Diphenyldihaloketones CLEFMA and EF24 With the 26S Proteasome

The proteasome is a validated target in drug discovery for diseases associated with unusual proteasomal activity. Here we report that two diphenyldihaloketones, CLEFMA and EF24, inhibit the peptidase activity of the 26S proteasome. The objective of this study was to investigate interaction of these...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Chem
Main Authors: Rao, Geeta, Nkepang, Gregory, Xu, Jian, Yari, Hooman, Houson, Hailey, Teng, Chengwen, Awasthi, Vibhudutta
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2018
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6153970/
https://ncbi.nlm.nih.gov/pubmed/30280096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fchem.2018.00392
Oznake: Označite
Brez oznak, prvi označite!